Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases.

Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases.:

Related Articles

Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases.

World J Clin Cases. 2020 Apr 26;8(8):1361-1384

Authors: Cheng FS, Pan D, Chang B, Jiang M, Sang LX

Abstract

Probiotics are known as "live microorganisms" and have been proven to have a health effect on hosts at the proper dose. Recently, a kind of probiotic mixture including eight live bacterial strains, VSL#3, has attracted considerable attention for its combined effect. VSL#3 is the only probiotic considered as a kind of medical food; it mainly participates in the regulation of the intestinal barrier function, including improving tight junction protein function, balancing intestinal microbial composition, regulating immune-related cytokine expression and so on. The objective of this review is to discuss the treatment action and mechanism for the administration of VSL#3 in chronic diseases of animals and humans (including children). We found that VSL#3 has a therapeutic or preventive effect in various systemic diseases per a large number of studies, including digestive systemic diseases (gastrointestinal diseases and hepatic diseases), obesity and diabetes, allergic diseases, nervous systemic diseases, atherosclerosis, bone diseases, and female reproductive systemic diseases.

PMID: 32368530 [PubMed]